ultra-rapid lispro Lyumjev
Selected indexed studies
- [Ultra-rapid lispro (Lyumjev®)]. (Rev Med Liege, 2021) [PMID:33443332]
- Ultra rapid lispro (Lyumjev®) shortens time to recovery from hyperglycaemia compared to Humalog® in individuals with type 1 diabetes on continuous subcutaneous insulin infusion. (Diabetes Obes Metab, 2024) [PMID:37814517]
- Ultra rapid lispro showed greater reduction in postprandial glucose versus Humalog in children, adolescents and adults with type 1 diabetes mellitus. (Diabetes Obes Metab, 2023) [PMID:36974352]
_Worker-drafted node — pending editorial review._
Connections
ultra-rapid lispro Lyumjev is a side effect of
Sources
- [Ultra-rapid lispro (Lyumjev®)]. (2021) pubmed
- Ultra rapid lispro (Lyumjev®) shortens time to recovery from hyperglycaemia compared to Humalog® in individuals with type 1 diabetes on continuous subcutaneous insulin infusion. (2024) pubmed
- Ultra rapid lispro showed greater reduction in postprandial glucose versus Humalog in children, adolescents and adults with type 1 diabetes mellitus. (2023) pubmed
- Ultra rapid lispro improves postprandial glucose control versus lispro in combination with basal insulin: a study based on CGM in type 2 diabetes in China. (2024) pubmed
- Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 Diabetes. (2024) pubmed
- Ultra-rapid lispro improved postprandial glucose control compared to insulin lispro in predominantly Chinese patients with type 1 diabetes: A prospective, randomized, double-blind phase 3 study. (2024) pubmed
- Ultra rapid lispro improves postprandial glucose control versus lispro in combination with insulin glargine/degludec in adults with type 2 diabetes: a prospective, randomized, double-blind, phase 3 trial. (2022) pubmed
- What is the value of faster acting prandial insulin? Focus on ultra rapid lispro. (2022) pubmed
- Ultra-rapid lispro or fast-acting aspart compared to standard insulin lispro and aspart using closed-loop insulin therapy: a systematic review and meta-analysis of randomized control trials. (2025) pubmed
- Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis. (2020) pubmed